Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2005-02-01
Metadata
Show full item recordCitation
Scand J Urol Nephrol 2005, 39(1):82-6Abstract
Homozygosity or mixed heterozygosity for mutations in the adenine phosphoribosyltransferase gene cause enzyme deficiency directing adenine through an alternative metabolic pathway. This results in the production of 2,8-dihydroxyadenine, which is actively secreted into the urine. 2,8-dihydroxyadenine is insoluble at physiological urinary pH but as marked supersaturation is possible the manifestations differ: there may be minimal consequences, there may be infiltration of the tubulointerstitial tissue with acute or chronic damage or there may be stone formation in the urinary tract. Effective treatment can be offered and therefore the prognosis depends upon the renal function at diagnosis. Treatment consists of adequate fluid intake, a low-purine diet and administration of allopurinol. Urinary 2,8-dihydroxyadenine crystals are easily recognized under a microscope. The diagnosis of 2,8-dihydroxyadeninuria can be confirmed by estimation of adenine phosphoribosyltransferase activity in erythrocyte lysates. More than 300 cases of 2,8-dihydroxyadeninuria have been diagnosed worldwide, most of them in Japan, France and Iceland. One case has been reported in Finland but there have been no reports from the Scandinavian peninsula or from Denmark. The relevant mutations may be very rare in these countries but underdiagnosis is also possible.Description
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldAdditional Links
http://dx.doi.org/10.1080/00365590510007621ae974a485f413a2113503eed53cd6c53
10.1080/00365590510007621
Scopus Count
Collections
Related articles
- [Acute renal failure and 2,8-dihydroxyadeninuria].
- Authors: Hoffmann M, Talaszka A, Bocquet JP, Le Monies de Sagazan H, Daudon M
- Issue date: 2004
- 2,8-Dihydroxyadeninuria--or when is a uric acid stone not a uric acid stone?
- Authors: Simmonds HA
- Issue date: 1979 Nov
- [Phosphoribosyltransferase (APRT) deficiency--molecular and clinical aspects of dihydroxyadeninuria].
- Authors: Safranow K
- Issue date: 1998
- [2,8-Dihydroxyadeninuria: 2.8-dihydroxyadenine crystals in urinary sediment in patients with adenine-phosphoribosyltransferase deficiency].
- Authors: Noro T, Ogiwara M, Okamura M
- Issue date: 1982 Dec 10
- [A case of adenine phosphoribosyltransferase (APRT) deficiency discovered by urine examination].
- Authors: Konishi N, Takeshita K, Yasui H
- Issue date: 1994 Oct